The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

EuroIntervention 2017;13:432-439 published online ahead of print May 2017. DOI: 10.4244/EIJ-D-17-00254

1. Medical Clinic I, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany; 2. Department of Cardiology, Vivantes Klinikum im Friedrichshain and Vivantes Klinikum Am Urban, Berlin, Germany, and Department of Cardiology, Universitätsmedizin Rost

Aims: We aimed to assess the safety and performance of the DREAMS 2G scaffold up to 24 months post implant.

Methods and res

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model